Trending...
- Constant Contact Appoints Russ Morton as Chief Product Officer
- CreateTV.com's New Chefs' Indian and Cuban Recipes will Spice Up Your Meals!
- IntellaTriage Hires New Director of Clinical Operations
Building the Future of Healthcare on Patient Engagement
FRAMINGHAM, Mass., Jan. 19, 2023 /PRNewswire/ -- Alira Health, a global healthcare advisory, clinical research and technology company, is pleased to announce today the appointment of Annabel de Maria as Chief Patient Officer. In this leadership capacity, she will spearhead the central role of patient engagement across Alira Health's continuum of healthcare innovation services. Annabel brings an extensive background and noteworthy experience with over twenty years in the healthcare industry, both as an in-house executive and freelance consultant, focusing on the patient-engagement sector. She originally joined Alira Health as Vice President of Patient Engagement in October 2020, and is based out of the firm's Barcelona, Spain office.
"At Alira Health, we truly believe that patients should be at the center of everything we do," said Gabriele Brambilla, CEO and Co-Founder of Alira Health. "I am proud to have Annabel leading in this critically important position as our Chief Patient Officer, in collaboration with all of our teams and services across Alira Health. Her guidance and leadership enables us to partner with patients throughout the whole lifecycle management of a drug or medical device. We work with clinical teams in co-developing clinical trial protocols with patients. We research diseases with patients from around the globe in order to understand the patient journey and apply the insights to trial protocols, regulatory submissions, Health Technology Assessments (HTAs), and commercialization. We help companies set up patient-centric strategies and build patient support programs. Alira Health is focused on co-creating healthcare solutions with patients for our clients. Annabel will play a critical role as we build the future of healthcare on patient engagement."
More on Boston Chron
"I am honored to bring the voice of the patient, in collaboration with teams across Alira Health, our clients, and our global partnerships, in this central role as Chief Patient Officer," Annabel de Maria said. "For over twenty-five years, I have focused my professional experience in pharma and MedTech on patient engagement, working to understand the patient journey throughout many important diseases and to implement groundbreaking plans to support and advocate for patients."
In her earlier role as Vice President of Patient Engagement, Annabel led Alira Health's Patient Engagement practice, where she helped clients introduce patient-centric activities into their organizations in a meaningful way. The practice is dedicated to helping organizations harness the power of patient insights, using them to make better decisions, impact outcomes, and enhance the patient experience. The practice's services include the development of patient-centric strategies, a patient knowledge center, advisory boards, and mobilization programs to facilitate true and fruitful interactions that serve stakeholders across the ecosystem and benefit patients.
Annabel assumes her role as Chief Patient Officer effective immediately. Prior to joining Alira Health, Annabel was Head of Corporate Communications at Almirall and Head of Media Relations Europe at Nestlé Purina. As a consultant, her work focused on global strategy for Champix, Lucentis, and Pradaxa. Annabel's early career included the Spanish launches of Celebrex, Detrusitol, and Xalatan, with later positions at Pfizer, Bayer, and Novartis Spain. In addition to her role at Alira Health, Annabel teaches patient engagement at the University of Bocconi, and she is the patient representative for the EULAR working group on autoinflammatory diseases.
More on Boston Chron
About Alira Health
Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle. Learn more: www.alirahealth.com
Photo - https://mma.prnewswire.com/media/1986878/Anna_de_Maria_lb_ID_3f14a4b22fa8.jpg
SOURCE Alira Health
FRAMINGHAM, Mass., Jan. 19, 2023 /PRNewswire/ -- Alira Health, a global healthcare advisory, clinical research and technology company, is pleased to announce today the appointment of Annabel de Maria as Chief Patient Officer. In this leadership capacity, she will spearhead the central role of patient engagement across Alira Health's continuum of healthcare innovation services. Annabel brings an extensive background and noteworthy experience with over twenty years in the healthcare industry, both as an in-house executive and freelance consultant, focusing on the patient-engagement sector. She originally joined Alira Health as Vice President of Patient Engagement in October 2020, and is based out of the firm's Barcelona, Spain office.
"At Alira Health, we truly believe that patients should be at the center of everything we do," said Gabriele Brambilla, CEO and Co-Founder of Alira Health. "I am proud to have Annabel leading in this critically important position as our Chief Patient Officer, in collaboration with all of our teams and services across Alira Health. Her guidance and leadership enables us to partner with patients throughout the whole lifecycle management of a drug or medical device. We work with clinical teams in co-developing clinical trial protocols with patients. We research diseases with patients from around the globe in order to understand the patient journey and apply the insights to trial protocols, regulatory submissions, Health Technology Assessments (HTAs), and commercialization. We help companies set up patient-centric strategies and build patient support programs. Alira Health is focused on co-creating healthcare solutions with patients for our clients. Annabel will play a critical role as we build the future of healthcare on patient engagement."
More on Boston Chron
- Entrinsik Board Announces New CEO
- Work & Mother Announces Collaboration with Jamestown to Provide State-of-the-Art Lactation Suites in Select Commercial Buildings
- Knobull Streamlines Presentation Techniques That Turns Stress Into Enjoyment
- Eddie Turner Ranked #13 On The Power List Of The Top 200 Biggest Voices In Leadership In 2023
- The Data Economics Company and Gordian Knot Strategies Announce Enkrateia Climate Investment Decision Support Platform
"I am honored to bring the voice of the patient, in collaboration with teams across Alira Health, our clients, and our global partnerships, in this central role as Chief Patient Officer," Annabel de Maria said. "For over twenty-five years, I have focused my professional experience in pharma and MedTech on patient engagement, working to understand the patient journey throughout many important diseases and to implement groundbreaking plans to support and advocate for patients."
In her earlier role as Vice President of Patient Engagement, Annabel led Alira Health's Patient Engagement practice, where she helped clients introduce patient-centric activities into their organizations in a meaningful way. The practice is dedicated to helping organizations harness the power of patient insights, using them to make better decisions, impact outcomes, and enhance the patient experience. The practice's services include the development of patient-centric strategies, a patient knowledge center, advisory boards, and mobilization programs to facilitate true and fruitful interactions that serve stakeholders across the ecosystem and benefit patients.
Annabel assumes her role as Chief Patient Officer effective immediately. Prior to joining Alira Health, Annabel was Head of Corporate Communications at Almirall and Head of Media Relations Europe at Nestlé Purina. As a consultant, her work focused on global strategy for Champix, Lucentis, and Pradaxa. Annabel's early career included the Spanish launches of Celebrex, Detrusitol, and Xalatan, with later positions at Pfizer, Bayer, and Novartis Spain. In addition to her role at Alira Health, Annabel teaches patient engagement at the University of Bocconi, and she is the patient representative for the EULAR working group on autoinflammatory diseases.
More on Boston Chron
- Best Pneumatic Air Jack for Cars (2023): VEVOR 5T Bag Air Jack Reviewed by Compare Before Buying
- Americana Songstress Emma Jo To Release Powerful New Single, 'Straight Into Mine'
- Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Fourth Quarter and Fiscal Year Ended December 31, 2022
- Boston: Mayor Michelle Wu, Superintendent Mary Skipper and Green New Deal Director Oliver Sellers-Garcia celebrate start of school bus fleet electrification
- IISE announces leadership election results
About Alira Health
Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle. Learn more: www.alirahealth.com
Photo - https://mma.prnewswire.com/media/1986878/Anna_de_Maria_lb_ID_3f14a4b22fa8.jpg
SOURCE Alira Health
Filed Under: Business
0 Comments
Latest on Boston Chron
- Boston Celtics and Sun Life close out 9th annual Fit to Win youth program with Celtics forward Justin Jackson at trampoline park
- Boston: Fire Prevention Program Manager Certificate
- Boston: Mayor Wu Announces Members of Steering Committee to Advise on Reforms to Article 80 Development Review Process
- Dog Licensing Reminder (and Boston's Most Popular Dog Names!)
- Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Urban One Inc's Reach Media Announces R&B Superstar Ralph Tresvant of New Edition as Host of "Love and R&B"
- ABP Acquisition to Acquire AlerisLife for $1.31 Per Share
- Berkshire Hills Announces Quarterly Shareholder Dividend
- Louisville Riverport Authority Applies To Include South Central Kentucky In Foreign Trade Zone #29 Service Area
- Santander Bank Raises Its Prime Rate to 7.75%
- Constant Contact Appoints Russ Morton as Chief Product Officer
- IntellaTriage Hires New Director of Clinical Operations
- CyberSaint STRONGER 2023 Conference Call for Speakers is Open!
- Metro Commercial brokers deal for BJ's Wholesale Club in West Palm Beach, FL
- L-Strategies political and business consulting firm launched by partners Angie Wong and Jared Craig with Donna and Stan Fitzgerald
- UPS Launches Services at Neighborhood Parcel Authorized Shipping Center In Tewksbury MA
- Zilker Partners Expands Recruiting and Digital Marketing Services to Keep Pace with Changing Business Climate
- CreateTV.com's New Chefs' Indian and Cuban Recipes will Spice Up Your Meals!
- Dental Tourism is on the Rise and This Dental Hygienist is Providing the Consultations
- Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023